These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34073490)

  • 1. Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients.
    Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Henke DM; Patel KD; Piedra FA; Angelo LS; Shah DP; Chemaly RF; Piedra PA
    Viruses; 2021 May; 13(6):. PubMed ID: 34073490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.
    Fuentes S; Hahn M; Chilcote K; Chemaly RF; Shah DP; Ye X; Avadhanula V; Piedra PA; Golding H; Khurana S
    J Infect Dis; 2020 Feb; 221(4):636-646. PubMed ID: 31745552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.
    Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
    Front Immunol; 2019; 10():706. PubMed ID: 30984206
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients.
    Ye X; Cabral de Rezende W; Iwuchukwu OP; Avadhanula V; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32326278
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients.
    Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
    J Infect Dis; 2018 Mar; 217(8):1247-1256. PubMed ID: 29365155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection with novel respiratory syncytial virus genotype Ontario (ON1) in adult hematopoietic cell transplant recipients, Texas, 2011-2013.
    Avadhanula V; Chemaly RF; Shah DP; Ghantoji SS; Azzi JM; Aideyan LO; Mei M; Piedra PA
    J Infect Dis; 2015 Feb; 211(4):582-9. PubMed ID: 25156562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants.
    Bonnin FA; Talarico LB; Ferolla FM; Acosta PL; Phung E; Kumar A; Toledano A; Caratozzolo A; Neira P; Mascardi N; Satragno D; Contrini MM; Graham BS; Ruckwardt TJ; López EL;
    Vaccine; 2024 Nov; 42(25):126119. PubMed ID: 39003106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels.
    Vissers M; Ahout IM; de Jonge MI; Ferwerda G
    Clin Vaccine Immunol; 2015 Dec; 23(3):243-5. PubMed ID: 26656116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.
    Walsh EE; Falsey AR
    J Infect Dis; 2004 Jul; 190(2):373-8. PubMed ID: 15216475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection.
    Capella C; Chaiwatpongsakorn S; Gorrell E; Risch ZA; Ye F; Mertz SE; Johnson SM; Moore-Clingenpeel M; Ramilo O; Mejias A; Peeples ME
    J Infect Dis; 2017 Dec; 216(11):1398-1406. PubMed ID: 29029312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas.
    Blunck BN; Aideyan L; Ye X; Avadhanula V; Ferlic-Stark L; Zechiedrich L; Gilbert BE; Piedra PA
    Vaccine; 2021 Feb; 39(8):1248-1256. PubMed ID: 33509697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults.
    Gonzalez IM; Karron RA; Eichelberger M; Walsh EE; Delagarza VW; Bennett R; Chanock RM; Murphy BR; Clements-Mann ML; Falsey AR
    Vaccine; 2000 Mar; 18(17):1763-72. PubMed ID: 10699324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection.
    Forster J; Maier O; Löbbert J; Kaufmehl K; Streckert HJ; Werchau H
    Infection; 1996; 24(6):407-11. PubMed ID: 9007586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies.
    Piedra PA; Jewell AM; Cron SG; Atmar RL; Glezen WP
    Vaccine; 2003 Jul; 21(24):3479-82. PubMed ID: 12850364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody and B cell responses to an investigational adjuvanted RSV vaccine for older adults.
    Weinberg A; Lambert SL; Canniff J; Yu L; Lang N; Esser MT; Falloon J; Levin MJ
    Hum Vaccin Immunother; 2019; 15(10):2466-2474. PubMed ID: 30852939
    [No Abstract]   [Full Text] [Related]  

  • 16. Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.
    Jounai N; Yoshioka M; Tozuka M; Inoue K; Oka T; Miyaji K; Ishida K; Kawai N; Ikematsu H; Kawakami C; Shimizu H; Mori M; Ishii KJ; Takeshita F
    EBioMedicine; 2017 Feb; 16():124-135. PubMed ID: 28111238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children.
    McFarland EJ; Karron RA; Muresan P; Cunningham CK; Perlowski C; Libous J; Oliva J; Jean-Philippe P; Moye J; Schappell E; Barr E; Rexroad V; Fearn L; Cielo M; Wiznia A; Deville JG; Yang L; Luongo C; Collins PL; Buchholz UJ
    J Infect Dis; 2020 Jun; 221(12):2050-2059. PubMed ID: 32006006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection.
    Yamazaki H; Tsutsumi H; Matsuda K; Nagai K; Ogra PL; Chiba S
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():2115-9. PubMed ID: 8046418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus.
    Jiao YY; Fu YH; Yan YF; Hua Y; Ma Y; Zhang XJ; Song JD; Peng XL; Huang J; Hong T; He JS
    Antiviral Res; 2017 Aug; 144():57-69. PubMed ID: 28529001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity.
    Maier C; Fuchs J; Irrgang P; Wißing MH; Beyerlein J; Tenbusch M; Lapuente D
    Front Immunol; 2022; 13():920256. PubMed ID: 36003372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.